Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

184 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical significance of macrophage heterogeneity in human malignant tumors.
Komohara Y, Jinushi M, Takeya M. Komohara Y, et al. Cancer Sci. 2014 Jan;105(1):1-8. doi: 10.1111/cas.12314. Epub 2013 Nov 29. Cancer Sci. 2014. PMID: 24168081 Free PMC article. Review.
Clearance of apoptotic cells is not impaired in mouse embryos deficient in class A scavenger receptor types I and II (CD204).
Komohara Y, Terasaki Y, Kaikita K, Suzuki H, Kodama T, Takeya M. Komohara Y, et al. Dev Dyn. 2005 Jan;232(1):67-74. doi: 10.1002/dvdy.20206. Dev Dyn. 2005. PMID: 15580571
AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype.
Komohara Y, Hirahara J, Horikawa T, Kawamura K, Kiyota E, Sakashita N, Araki N, Takeya M. Komohara Y, et al. J Histochem Cytochem. 2006 Jul;54(7):763-71. doi: 10.1369/jhc.5A6871.2006. Epub 2006 Mar 3. J Histochem Cytochem. 2006. PMID: 16517975
Detection of guinea pig macrophages by a new CD68 monoclonal antibody, PM-1K.
Horikawa T, Komohara Y, Kiyota E, Terasaki Y, Takagi K, Takeya M. Horikawa T, et al. Among authors: komohara y. J Mol Histol. 2006 Jan;37(1-2):15-25. doi: 10.1007/s10735-006-9025-x. Epub 2006 May 19. J Mol Histol. 2006. PMID: 16710801
Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K, Matsumoto K, Inomata Y, Komohara Y, Miyajima S, Takeya M, Tanihara H. Ikema K, et al. Among authors: komohara y. Exp Eye Res. 2006 Dec;83(6):1396-404. doi: 10.1016/j.exer.2006.07.019. Epub 2006 Sep 11. Exp Eye Res. 2006. PMID: 16968651
Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy.
Azuma K, Komohara Y, Sasada T, Terazaki Y, Ikeda J, Hoshino T, Itoh K, Yamada A, Aizawa H. Azuma K, et al. Among authors: komohara y. Cancer Sci. 2007 Sep;98(9):1336-43. doi: 10.1111/j.1349-7006.2007.00557.x. Epub 2007 Jul 19. Cancer Sci. 2007. PMID: 17640298
Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients.
Suekane S, Nishitani M, Noguchi M, Komohara Y, Kokubu T, Naitoh M, Honma S, Yamada A, Itoh K, Matsuoka K, Kanayama H. Suekane S, et al. Among authors: komohara y. Cancer Sci. 2007 Dec;98(12):1965-8. doi: 10.1111/j.1349-7006.2007.00631.x. Epub 2007 Oct 5. Cancer Sci. 2007. PMID: 17919310 Clinical Trial.
HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma.
Komohara Y, Harada M, Ishihara Y, Suekane S, Noguchi M, Yamada A, Matsuoka K, Itoh K. Komohara Y, et al. Oncol Rep. 2007 Dec;18(6):1463-8. Oncol Rep. 2007. PMID: 17982631
Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients.
Jin M, Komohara Y, Shichijo S, Yamanaka R, Nikawa J, Itoh K, Yamada A. Jin M, et al. Among authors: komohara y. Cancer Sci. 2008 Aug;99(8):1656-62. doi: 10.1111/j.1349-7006.2008.00866.x. Cancer Sci. 2008. PMID: 18754880
Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors.
Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M. Kawamura K, et al. Among authors: komohara y. Pathol Int. 2009 May;59(5):300-5. doi: 10.1111/j.1440-1827.2009.02369.x. Pathol Int. 2009. PMID: 19432671
184 results
Jump to page
Feedback